| Description | IRAK4-IN-26 (Compound 21), an IRAK4 inhibitor with an IC50 of 6.2 nM, exhibits an oral bioavailability of 21%. It is utilized for the study of inflammatory and autoimmune disorders [1]. |
| molecular weight | 405.45 |
| Molecular formula | C22H23N5O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |